Core Insights - Equity Lifestyle Properties (ELS) reported a revenue of $376.87 million for the quarter ended June 2025, reflecting a year-over-year decline of 0.8% and a surprise of -2.89% compared to the Zacks Consensus Estimate of $388.1 million [1] - The earnings per share (EPS) for the same period was $0.69, which is an increase from $0.42 a year ago, aligning with the consensus EPS estimate [1] Revenue Breakdown - Interest income was reported at $2.2 million, below the estimated $2.33 million, representing a year-over-year decline of 9% [4] - Annual membership subscriptions generated $16.9 million, exceeding the average estimate of $16.47 million [4] - Income from other investments, net, was $2.08 million, lower than the estimated $2.47 million, showing a year-over-year decrease of 20.8% [4] - Rental income amounted to $313.29 million, slightly above the estimated $311.95 million, with a year-over-year increase of 4.2% [4] - Other income was reported at $16.47 million, close to the average estimate of $16.59 million, reflecting a year-over-year increase of 1.7% [4] - Membership upgrade sales for the current period grossed $3.12 million, below the average estimate of $4.11 million [4] Stock Performance - Shares of Equity Lifestyle Properties have returned -1.3% over the past month, contrasting with the Zacks S&P 500 composite's +5.4% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Viewpoint - Labcorp Holdings (LH) is expected to report quarterly earnings of $4.14 per share, reflecting a 5.1% increase year-over-year, with revenues projected at $3.49 billion, an 8.3% increase from the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised down by 0.1% in the last 30 days, indicating a reassessment by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Revenues- Biopharma Laboratory Services' at $743.20 million, a 5.1% increase from the prior-year quarter [5]. - The average estimate for 'Revenues- Diagnostics Laboratories' is $2.74 billion, reflecting an 8.7% increase year-over-year [5]. Operating Income Estimates - 'Adjusted Operating Income- Biopharma Laboratory Services' is projected to reach $117.62 million, up from $107.40 million in the same quarter last year [6]. - 'Adjusted Operating Income- Diagnostics Laboratories' is expected to be $466.41 million, compared to $441.50 million a year ago [6]. Stock Performance - Labcorp shares have returned -6.9% over the past month, contrasting with the Zacks S&P 500 composite's +5.4% change [6]. - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [6].

Wall Street analysts expect Northern Trust Corporation (NTRS) to post quarterly earnings of $2.08 per share in its upcoming report, which indicates a year-over-year increase of 16.9%. Revenues are expected to be $1.98 billion, down 27% from the year-ago quarter.Over the last 30 days, there has been an upward revision of 4.6% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course ...

Core Viewpoint - Tri Pointe Homes (TPH) is expected to report a significant decline in quarterly earnings and revenues, indicating challenges in the homebuilding sector [1][4]. Financial Performance Estimates - Analysts predict TPH will post quarterly earnings of $0.66 per share, a decrease of 47.2% year-over-year [1]. - Revenue is forecasted at $790.57 million, reflecting a year-over-year decline of 30.2% [1]. - The consensus estimate for 'Total revenues- Homebuilding- Home sales revenue' is $790.56 million, also down 30.2% from the previous year [4]. - 'Total revenues- Financial Service' is expected to be $18.89 million, showing an increase of 11.3% year-over-year [4]. Key Operational Metrics - 'New homes delivered' is estimated at 1,154, down from 1,700 in the same quarter last year [5]. - 'Net new home orders' are projected at 1,316, compared to 1,651 in the previous year [5]. - 'Selling communities at end of period' is expected to remain at 153, unchanged from the same quarter last year [5]. Pricing and Backlog Insights - The 'Average sales price in backlog' is anticipated to reach $757.80, up from $743.00 in the same quarter last year [6]. - The 'Average sales price of homes delivered' is projected at $686.14, compared to $666.00 in the previous year [6]. - The estimated 'Backlog (estimated dollar value)' is $1.42 billion, down from $2.00 billion in the same quarter last year [7]. - 'Backlog (homes)' is expected to be 1,876, a decrease from 2,692 in the previous year [7]. Income Projections - 'Income before income taxes- Financial services' is forecasted at $5.76 million, down from $6.08 million in the same quarter last year [8]. - 'Income before income taxes- Homebuilding' is expected to be $74.45 million, significantly lower than $153.15 million reported in the previous year [8]. Market Performance - TPH shares have increased by 8.1% over the past month, outperforming the Zacks S&P 500 composite, which rose by 5.4% [8].

Core Insights - Wall Street analysts expect Sherwin-Williams (SHW) to report quarterly earnings of $3.76 per share, reflecting a year-over-year increase of 1.6% [1] - Revenues are projected to be $6.29 billion, which is a slight increase of 0.2% from the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a reevaluation of initial estimates by analysts [1] Revenue Estimates - Analysts predict 'Net sales- Paint Stores Group' to be $3.68 billion, representing a year-over-year increase of 1.6% [4] - 'Net sales- Consumer Brands Group' is expected to reach $826.14 million, indicating a decline of 2.2% year over year [4] - 'Net sales- Performance Coatings Group' is estimated at $1.77 billion, suggesting a decrease of 1.7% from the previous year [4] Store Metrics - The 'Net New Stores - Paint Stores Group' is projected to reach 20, up from 19 in the same quarter last year [5] - The expected 'Number of Stores - Paint Stores Group' is 4,811, compared to 4,720 a year ago [5] Profit Estimates - 'Segment Profit- Paint Stores Group' is anticipated to be $946.70 million, an increase from $907.10 million in the same quarter last year [6] - 'Adjusted segment profit- Performance Coatings Group (PCG)' is expected to be $337.39 million, down from $350.50 million year over year [6] - 'Adjusted segment profit- Consumer Brands Group (CBG)' is projected at $213.90 million, compared to $220.40 million in the previous year [7] Stock Performance - Over the past month, Sherwin-Williams shares have returned +2.5%, while the Zacks S&P 500 composite has changed by +4.2% [7] - Based on its Zacks Rank 2 (Buy), SHW is expected to outperform the overall market in the upcoming period [7]

Overview - Investopedia 分析了过去五任总统（乔·拜登、唐纳德·特朗普、巴拉克·奥巴马、乔治·W·布什和比尔·克林顿）任期内表现最佳的股票 [1] Resource - 完整的文章链接为：https://t.co/yci8MECLco https://t.co/OuI1xKalBi [1]

Core Insights - FB Financial (FBK) reported a revenue of $137.41 million for the quarter ended June 2025, marking a year-over-year increase of 7.2% and exceeding the Zacks Consensus Estimate of $135.28 million by 1.58% [1] - The company's EPS for the same period was $0.88, slightly below the consensus estimate of $0.89, reflecting an EPS surprise of -1.12% compared to $0.84 a year ago [1] Financial Performance Metrics - Efficiency Ratio stood at 56.9%, better than the three-analyst average estimate of 57.3% [4] - Net Interest Margin was reported at 3.7%, surpassing the average estimate of 3.6% based on three analysts [4] - Average Earning Assets totaled $12.24 billion, below the two-analyst average estimate of $12.57 billion [4] - Net Charge-offs during the period to Average Loans outstanding were 0%, compared to the average estimate of 0.1% [4] - Mortgage banking income reached $13.03 million, exceeding the three-analyst average estimate of $12.8 million [4] - Total Noninterest income was $26 million, higher than the average estimate of $24.69 million [4] - Net interest income (tax-equivalent basis) was $112.24 million, slightly above the average estimate of $111.95 million [4] - Other Income amounted to $2.54 million, compared to the average estimate of $2.25 million [4] - Service charges on deposit accounts were $3.39 million, slightly below the average estimate of $3.46 million [4] - Net Interest Income was reported at $111.42 million, marginally below the two-analyst average estimate of $111.61 million [4] - ATM and interchange fees totaled $2.88 million, exceeding the two-analyst average estimate of $2.83 million [4] - Investment services and trust income reached $3.92 million, surpassing the two-analyst average estimate of $3.63 million [4] Stock Performance - FB Financial shares have returned +11.6% over the past month, outperforming the Zacks S&P 500 composite's +4% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Core Viewpoint - Analysts forecast that Elevance Health (ELV) will report quarterly earnings of $9.20 per share, indicating a year-over-year decline of 9.1%, while revenues are expected to reach $48.13 billion, reflecting an increase of 11.4% compared to the previous year [1] Revenue Estimates - The consensus estimate for 'Revenues- Premiums' is $39.62 billion, suggesting a year-over-year increase of 11.9% [5] - 'Revenues- Service fees' are expected to be $2.24 billion, indicating a decline of 1.8% year over year [5] - 'Revenues- Net investment income' is projected at $464.67 million, reflecting a decrease of 8.5% from the year-ago quarter [5] - 'Revenues- Product revenue' is forecasted to reach $6.14 billion, showing an increase of 11.1% from the previous year [6] Membership Estimates - 'Medical Membership - Medicare - Medicare Supplement' is expected to be 868.88 thousand, down from 894.00 thousand year over year [6] - 'Medical Membership - Commercial Risk-Based - Employer Group Risk-Based' is projected at 3.64 million, slightly down from 3.65 million in the same quarter last year [7] - 'Medical Membership - Commercial Risk-Based' is estimated at 5.00 million, up from 4.93 million year over year [7] - Total Medical Membership is expected to be 45.83 million, a slight increase from 45.78 million year over year [8] - 'Medical Membership - Medicare - Medicare Advantage' is projected to reach 2.24 million, up from 2.03 million year over year [8] - 'Medical Membership - Medicaid' is expected to be 8.86 million, down from 9.03 million year over year [9] - 'Medical Membership - Federal Employees Health Benefits' is projected at 1.65 million, slightly down from 1.66 million year over year [9] Stock Performance - Over the past month, shares of Elevance Health have returned -11.4%, contrasting with the Zacks S&P 500 composite's +4% change [9]

Core Viewpoint - Nvidia shares have increased by approximately 11.4% since the last earnings report, outperforming the S&P 500, raising questions about the sustainability of this positive trend leading up to the next earnings release [1] Group 1: Earnings Report and Estimates - Fresh estimates for Nvidia have trended upward over the past month, indicating positive sentiment among analysts [2] - The most recent earnings report serves as a catalyst for understanding the stock's performance and future outlook [1] Group 2: VGM Scores - Nvidia has a strong Growth Score of A, but is lagging in Momentum Score with an F, and has a Value Score of D, placing it in the bottom 40% for that investment strategy [3] - The aggregate VGM Score for Nvidia is C, which is relevant for investors not focused on a single strategy [3] Group 3: Outlook - The upward trend in estimates suggests a promising outlook for Nvidia, with a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4]

Core Insights - McCormick reported revenue of $1.66 billion for the quarter ended May 2025, reflecting a 1% increase year-over-year, with EPS remaining stable at $0.69 compared to the same quarter last year [1] - The revenue fell short of the Zacks Consensus Estimate by -0.22%, while the EPS exceeded the consensus estimate by +6.15% [1] Financial Performance - Net Sales in Flavor Solutions were reported at $729 million, which is -1.3% lower than the estimated $746.82 million [4] - Net Sales in the Consumer segment reached $931 million, surpassing the estimated $918.28 million, marking a year-over-year increase of +2.9% [4] - Operating income for Flavor Solutions, excluding special charges, was $95 million, exceeding the average estimate of $92.07 million [4] - Operating income for the Consumer segment was reported at $164 million, also above the average estimate of $152.43 million [4] Stock Performance - McCormick's shares have returned +3.2% over the past month, underperforming the Zacks S&P 500 composite's +5.1% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]